Groups

Research Focus

Former Employee. Pediatrics; Special Fellow

Recent additions – View all

1. Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors

   Meeting Abstract

   Marks, L. J.; Diolaiti, D.; Mundi, P. S.; Gaviria, E.; Rainey, A.; Dela Cruz, F.; Califano, A.; Kung, A.
   Journal of Clinical Oncology (2018)

   Fulltext@MSK | Save
2. Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors

   Meeting Abstract

   Marks, L.; Diolaiti, D.; Mundi, P.; Gaviria, E.; Rainey, A.; Dela Cruz, F.; Andrea, C.; Kung, A.
   Pediatric Blood and Cancer (2018)

   Fulltext@MSK | Save
3. Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group

   Journal Article

   Marks, L. J.; Pei, Q.; Bush, R.; Buxton, A.; Appel, B.; Kelly, K. M.; Schwartz, C. L.; Friedman, D. L.
   Pediatric Blood and Cancer (2018)

   Fulltext@MSK | Save